What We're Reading: Page 307
Industry reads hand-picked by our editors
Apr 20, 2017
-
Bloomberg
Google’s health moonshot comes back to Earth
-
Reuters
Gates backs big pharma push to wipe out tropical diseases
-
Business Insider
We just got a better idea of how much drug companies rely on price hikes, and it doesn't look good
-
Forbes
Meet the top VC in a race to find his own Parkinson's cure
-
Voice of America
Overcoming opioids: The quest for less addictive drugs
Apr 19, 2017
Apr 18, 2017
-
NPR
Nonprofit working to block drug imports has ties to pharma lobby
-
Business Insider
The makers of a lethal-injection drug have become leaders in Arkansas' death-penalty battle
-
Xconomy
Cancer drugmaker G1 Therapeutics makes IPO Pitch to Wall Street
-
Forbes
The billionaire and the drug price-fixing scandal
Apr 17, 2017
-
Forbes
Apple and Google, the next big pharma
-
The Sacramento Bee
Can California’s ‘right to try’ law help save terminal patients?
-
The Guardian
Scarcity of meningitis vaccine persists as epidemic worsens
-
MarketWatch
Pharma companies are seeking a new treatment — for the backlash against high drug prices
Apr 13, 2017
-
The New Yorker
Martin Shkreli is still talking
-
EP Vantage
Price restraint talks hit reality bump
-
Buzzfeed News
Can a simple blood test really spot cancer early? Don’t bet on it yet, scientists say
-
Science
Human ‘knockouts’ may reveal why some drugs fail
Apr 12, 2017
-
TheStreet
For these small-cap biotech CEOs, stock promotion, not drug development, was priority No. 1
-
Forbes
Democrats propose a $2 billion prize fund for new antibiotics
-
MIT Technology Review
Can “digital therapeutics” be as good as drugs?
-
HR Dive
Employers 'relieved' over AHCA's demise, but still seeking specialty pharma assistance
Apr 11, 2017
-
Reuters
SEC targets fake stock news on financial websites
-
Axios
Merck's CEO doubles his pay
-
The Wall Street Journal
China emerges as powerhouse for biotech drugs
-
Kaiser Health News
Drugmakers help turn patients with rare diseases into D.C. lobbyists
Previous
